15 results

wha69-assembly-hall-large
Global

Posted on 17.05.2017

World Health Assembly kicks off next week

The world’s highest health policy-setting body, World Health Assembly (WHA), is set to hold its 70th annual meeting in Geneva from 22-31 May 2017. It is here that health ministers from the World Health Organization’s (WHO’s) 194 member states will review the WHO’s work, set new goals and assign new tasks. Delegates at #WHA70 are […]

By Karen Finn Freelance writer, editor

MTV_AMR
Digital

Posted on 10.02.2016

New rapid diagnostic technology will change the way we use antibiotics

With the convergence of electronics, biology and mobile technologies, nowhere is the transformative potential of rapid point of care testing better illustrated than in the challenge to overcome antibiotic resistance. It is widely acknowledged that growing resistance to antibiotics poses a global health threat. The World Health Organisation has said that our ability to treat […]

By Dr. Dale Athey Managing Director, OJ Bio

horizon2020_1
Value

Posted on 15.04.2015

Horizon Prize for better use of antibiotics – Compete, innovate and win €1 million!

The European Commission launched a €1 million prize for a diagnostic test to combat antibiotic resistance. The challenge is to develop a rapid test that will allow healthcare providers to distinguish, at the point of care, between patients with upper respiratory tract infections that require antibiotics and those that can be treated safely without antibiotics. […]

superbugs-approach
Value

Posted on 18.11.2014

How can we approach this era of superbugs and healthcare-associated infections

Today is European Antibiotic Awareness Day. Tackling the era of superbugs should be a team sport. Physicians, companies, foundations and the MedTech industry all want to play their part.

superbugs-physicianview_1
Value

Posted on 29.07.2014

Superbugs: “The physician community needs to get its act together”

The WHO has been raising the ‘threat level’ on this issue progressively each year for the last decade, with individual disease reports highlighting the emerging threat of antimicrobial resistance (AMR). This year’s report however highlights this pandemic like never before, demonstrating it’s global nature and its profound impact on health and economics. I’m a cardiologist and the report speaks to me – actually it screams out loud: “We need to get our act together”.

By Sameer Bansilal Attending Physician in the Mount Sinai Cardiovascular Institute

superbugs-industryview
Value

Posted on 16.07.2014

Superbugs and the role of diagnostics explained

The discussion over superbugs moved center stage earlier this month when British Prime Minister David Cameron launched a global review of the crisis. “If we fail to act, we are looking at an almost unthinkable scenario where antibiotics no longer work and we are cast back into the dark ages of medicine where treatable infections […]

By Jürgen Schulze President of Sysmex EMEA, EDMA President, Chairman of MedTech Europe Board